Research article · 2014
Research articlePublished 30 Jun 2017
Clinical Significance of Beclin-1 Dependent Autophagy Induced by Imatinib in Chronic Myeloid Leukemia Patients
1Clinical Pathology Department, Faculty of Medicine, Minia University, Egypt; 2Clinical Pathology Department, Faculty of Medicine, Assiut University, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background and objectives: The introduction of imatinib as one of the tyrosine kinase inhibitors (TKI) has revolutionized the treatment of chronic myelogenous leukemia (CML), representing the first target specific drug. Autophagy is a constitutive homeostatic mechanism for intracellular recycling and metabolic regulation. The role of autophagy in cancer is very complex, it is tumor suppression mechanism yet it enables tumor cell survival in stress. The aim of the present study was to assess autophagy induced by imatinib therapy through beclin-1 gene in CML patients, and to evaluate beclin-1 gene expression in relation to patients’ clinical and hematological response. Subjects and methods: The present study was carried out on 50 subjects, 35 newly diagnosed CML patients who were classified into 2 groups: (Group I) including 17 CML patients and (Group II) including 18 CML patients in accelerated phase, and 15 apparently healthy subjects served as controls (Group III). All patients were treated with imatinib and followed up after six weeks of treatment. Each patient was subjected to complete history taking, clinical examination along with laboratory investigations in the form of liver & renal function tests, random blood glucose, ESR, CBC & examination of Leishman-stained peripheral blood and Bone marrow aspiration and examination of Leishman-stained smears. The diagnosis was confirmed by detection of BCR-ABL gene expression by quantitative RT-PCR. Beclin-1 gene expression in peripheral blood samples was assessed as well via quantitative RT-PCR for all subjects along with its reassessment in follow-up samples for all patients. Results: All patients in the study have achieved complete clinical and hematological response after six weeks of the beginning of imatinib therapy along with a highly significant increase in beclin-1 gene expression levels after treatment, (P<0.001) than before treatment in both patients groups I & II. There was no significant difference between group I & group II, regarding beclin-1 gene expression results after treatment (p=0.631). There was a high statistically significant negative correlation between beclin-1 gene expression before treatment and BCR-ABL gene expression results (r=-0.844 & -0.822) in group I and II respectively. Conclusions: We concluded that beclin-1 dependent autophagy is increased after the beginning of imatinib therapy indicating induction of autophagy in CML patients, along with complete clinical and hematological response.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 26 Jun 2017
Hyaluronan reverses Imatinib dependent-senescence in chronic myeloid leukemia cell lines
Conference abstract · 20 Jul 2017
PDGFRα promoter polymorphisms and their expression pattern influence risk of development of Imatinib-induced thrombocytopenia in chronic myeloid leukemia
Research article · 2015
Phytohemagglutinin-Induced Peripheral Blood Cytogenetics: A Valid Means for Diagnosis and Imatinib Therapy Monitoring of Chronic Phase Chronic Myeloid Leukemia Patients
Research article · 8 Feb 2019
Sex and Major Molecular Response to Imatinib Treatment for Patients with Chronic Myeloid Leukemia
More from this journal
The newest in Journal of Mucosal Immunology Research.
Perspective · 29 May 2025
Gut T-cell Regulation: IBD Therapies
Perspective · 29 May 2025
Gut Microbiota: Diet, Inflammation, and Homeostasis
Perspective · 29 May 2025
Airway Mucosa: Inflammation, Microbiome, and Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Mucosal Immunology Research
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Esmat A. El-Sharkawy”
- BylineArticles whose byline prints “Khalid M. Salah”
- BylineArticles whose byline prints “Amel Mahmoud Kamal Eldin”
- BylineArticles whose byline prints “Ayman Gamil Ghobrial”
- BylineArticles whose byline prints “Walid M. Abdel-Hamid”
- BylineArticles whose byline prints “Eman Hassan”
- BylineArticles whose byline prints “Rasha Y. Ali”
